Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02652533 · ClinicalTrials.gov registry record
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
A clinical trial of Biliary Atresia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 41
- Enrollment target
- 4
- Study locations
NCT02652533: Completed study of Biliary Atresia, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02652533 is a study of Biliary Atresia that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 41 participants, below the 569-participant average among 7 other Biliary Atresia trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02652533, a study of Biliary Atresia, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators plan to investigate the use of US shear wave elastography (SWE), a newly available imaging technology, in children with suspected/known BA.
Primary Outcome
The primary outcome measure will be ultrasound shear wave speed of the liver. The investigators will compare the mean liver shear wave speed measurements in children with biliary atresia to other liver diseases. Sensitivity and specificity of ultrasound for diagnosing biliary atresia will be determined using multiple shear wave speed cut-off values.
Conditions Studied
Interventions
- DEVICE Ultrasound Shear Wave Elastography
Study Locations (4)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's - Columbus
California
- Lucile Packard Children's Hospital/Stanford University - Stanford
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-07 |
What the finished NCT02652533 record still lists
NCT02652533 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 569-participant average among 7 other Biliary Atresia trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Biliary Atresia appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Shear Wave Elastography is the first listed.
NCT02652533 reports a single indexed study location in Ohio, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT02652533 about?
NCT02652533 is a clinical study titled "Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia". The investigators plan to investigate the use of US shear wave elastography (SWE), a newly available imaging technology, in children with suspected/known BA.
What is the current status of trial NCT02652533?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2016-09. Estimated completion is 2019-07.
What conditions does trial NCT02652533 study?
This clinical trial studies the following conditions: Biliary Atresia.
What interventions are being tested in trial NCT02652533?
The interventions under investigation include: Ultrasound Shear Wave Elastography (DEVICE).
Who is sponsoring clinical trial NCT02652533?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02652533 being conducted?
This trial has 4 study locations across California, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Atresia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Disease Pathways for Biliary Atresia
RECRUITING
-
Biliary Atresia Research Network Northeast
RECRUITING
-
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
RECRUITING · Phase 1
-
A Prospective Database of Infants With Cholestasis
RECRUITING
-
Biliary Atresia Study in Infants and Children
RECRUITING
-
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia